Dropout rate in clinical trials of smartphone apps for diabetes management: A meta-analysis
Authors' conclusion
Given the high dropout rate, the engagement level toward diabetic management apps in real-world setting is expected to be low.
Study context
- Population
- Clinical trials of smartphone apps for control of T1D or T2D
- Participants
- 3,327 participants36 studies
- Outcome
- Dropout rate
Methodological detailsPRISMA guideline, Literature search 4 September 2023: PubMed, Scilit, Scopus, Embase, Web of Science; 5,429 records identified
- PRISMA guideline
- Literature search 4 September 2023: PubMed, Scilit, Scopus, Embase, Web of Science; 5,429 records identified
Pooled result
As reported in the abstract
Overall dropout rate
Overall dropout rate
29.6 %
95% CI 25%–34.3%
Heterogeneity
p-Het < 0.001; I2 = 84.84 %
Further pooled results
Moderators (sample size, intervention duration, age, gender, cultural adaptation)
- Non-significant moderators
- P > 0.05
Dropout rate in subgroups
%
- Studies performing cultural adaptation
- 34.6
- Studies conducted in high-income countries
- 31.9
Original publication
Dropout rate in clinical trials of smartphone apps for diabetes management: A meta-analysis. Diabetes Res Clin Pract. Published 1 June 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →